eugene isenberg a $100 million payout. the "wall street journal reported that 81-year-old isenberg is getting the rich payout even though he's staying on as chairman of the company. a clause in his contract stipulates the payment in case of a "change in responsibility." in the past 20 years, not counting the latest sum, but including the value of exercised stock options, isenberg has made almost $750 million, according to standard & poor's execucomp. nabors recently reported a third-quarter profit of $74 million, versus a loss last year. prescription drug costs are a major concern. quality concerns and industry consolidation are some of the reasons manufacturers aren't making enough drugs for everyone who needs them. today president obama announced an initiative to help prevent drug shortages. darren gersh reports. >> reporter: flanked by a cancer patient and a hospital pharmacy manager, the president today warned of the risks of growing shortages of drugs. >> this is one of those slow- rolling problems that could end up r